Can a health advocate prevent organ rejection in kids after liver transplant?
NCT ID NCT07279350
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a health advocate can help families of children who recently had a liver transplant. The advocate works with the family for 90 days to find resources, coordinate appointments, and communicate concerns to the medical team. The goal is to see if this support reduces organ rejection and improves outcomes. About 108 families will take part, with half receiving the advocate and half getting a resource handout.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
health advocate (behavioural intervention)
What this could lead to
If it works, this could show that a health advocate helps families manage care after a child's liver transplant, potentially reducing organ rejection and improving long-term health.
What could go wrong
This is a small, early-stage trial with only 108 participants, so results may not apply to everyone. The intervention is short (90 days) and may not have lasting effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC LIVER TRANSPLANTED RECIPIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94158, United States